Therefore, it may lead to elevated expression levels of IFN signatures, including TNFSF13B and OAS1, suggesting that activation of IFN-related pathways may also be an essential feature of MetS, which is the same as SLE. The gene discussed is OAS1; the disease is metabolic syndrome.